Shoma Nishibori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shoma Nishibori has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Kenji Baba
Laboratory of Veterinary Internal Medicine, Joint Graduate School of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
2 shared publications - Satoshi Kambayashi
Laboratory of Veterinary Internal Medicine, Joint Graduate School of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
2 shared publications - Hiro Horikirizono
Laboratory of Veterinary Radiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753-8515, Japan
1 shared publication - Hiroki Ikezawa
Animal Medical Technology Co., Ltd., Nagoya, Aichi, Japan
1 shared publication - Hiroshi Sunahara
Department of Veterinary Surgery , Yamaguchi , Japan
1 shared publication - Kazuhito Itamoto
Affiliation Department of Small Animal Clinical Science, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi City, Yamaguchi, Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1) , 3714485
Suspected Macrocreatine Kinase Type 1 in an Asymptomatic Young Cat
A 1‐year‐old castrated male Japanese domestic cat was referred for persistently elevated serum creatine kinase (CK) level (> 2000 U/L), which was detected incidentally. The cat showed no clinical signs, with no abnormalities on physical examination, radiography, and ultrasonography. Serum CK isoenzyme analysis by agarose gel electrophoresis revealed an atypical high distribution of CK‐MB (90%). However, CK‐MB–specific quantification by chemiluminescent immunoassay showed significantly low concentration (< 0.1 ng/mL). Based on these observations, we suspected macro‐CK type 1. Serum CK is used as a biomarker of muscle injury in both humans and other mammals. Macro‐CK type 1, a complex of CK and immunoglobulin, has been recognized as the cause of persistently elevated CK levels with or without disease in human medicine. On the other hand, reports of macro‐CK are scarce in veterinary medicine. Based on this case, when persistently elevated CK was detected in clinically healthy cats, this disease should be included as a differential diagnosis. Further studies are required to establish the diagnosis of macro‐CK type 1 in cats.
- 1 January 2026
- Published by Wiley in Case Reports in Veterinary Medicine
- Vol. 2026 (1) , 3714485
Open AccessSuspected Macrocreatine Kinase Type 1 in an Asymptomatic Young Cat
A 1‐year‐old castrated male Japanese domestic cat was referred for persistently elevated serum creatine kinase (CK) level (> 2000 U/L), which was detected incidentally. The cat showed no clinical signs, with no abnormalities on physical examination, radiography, and ultrasonography. Serum CK isoenzyme analysis by agarose gel electrophoresis revealed an atypical high distribution of CK‐MB (90%). However, CK‐MB–specific quantification by chemiluminescent immunoassay showed significantly low concentration (< 0.1 ng/mL). Based on these observations, we suspected macro‐CK type 1. Serum CK is used as a biomarker of muscle injury in both humans and other mammals. Macro‐CK type 1, a complex of CK and immunoglobulin, has been recognized as the cause of persistently elevated CK levels with or without disease in human medicine. On the other hand, reports of macro‐CK are scarce in veterinary medicine. Based on this case, when persistently elevated CK was detected in clinically healthy cats, this disease should be included as a differential diagnosis. Further studies are required to establish the diagnosis of macro‐CK type 1 in cats.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (1) , e15
Proof-of-concept study of the caninized anti-canine programmed death 1 antibody in dogs with advanced non-oral malignant melanoma solid tumors
Igase M, et al. J Vet Sci. 2024 Jan;25(1):e15. https://doi.org/10.4142/jvs.23144
- 1 January 2024
- Published by XMLink in Journal of Veterinary Science
- Vol. 25 (1) , e15
Top Cited PapersOpen AccessProof-of-concept study of the caninized anti-canine programmed death 1 antibody in dogs with advanced non-oral malignant melanoma solid tumors
Igase M, et al. J Vet Sci. 2024 Jan;25(1):e15. https://doi.org/10.4142/jvs.23144